Extracellular vesicle-based therapy for amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) stands as a neurodegenerative disorder characterized by the rapid progression of motor neuron loss in the brain and spinal cord. Unfortunately, treatment options for ALS are limited, and therefore, novel therapies that prevent further motor neuron degeneration are...
Main Authors: | Nadia Sadanandan, Jea-Young Lee, Svitlana Garbuzova-Davis |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2021-01-01
|
Series: | Brain Circulation |
Subjects: | |
Online Access: | http://www.braincirculation.org/article.asp?issn=2394-8108;year=2021;volume=7;issue=1;spage=23;epage=28;aulast=Sadanandan |
Similar Items
-
Revealing the Proteome of Motor Cortex Derived Extracellular Vesicles Isolated from Amyotrophic Lateral Sclerosis Human Postmortem Tissues
by: Natasha Vassileff, et al.
Published: (2020-07-01) -
Role of Extracellular Vesicles in Amyotrophic Lateral Sclerosis
by: Deborah Ferrara, et al.
Published: (2018-08-01) -
Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis
by: G.Y. Wang, et al.
Published: (2020-03-01) -
Extracellular Vesicles and the Quest for Molecular Biomarkers for Amyotrophic Lateral Sclerosis
by: Manser, Charlotte
Published: (2020) -
Extracellular vesicles in physiology, pathology and therapy of the immune and central nervous system, with focus on extracellular vesicles derived from mesenchymal stem cells as therapeutic tools
by: Sylwia eKoniusz, et al.
Published: (2016-05-01)